| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $164.9M | +52.0% |
| R&D Expense | $27.9M | +6.8% |
| SG&A Expense | $45.3M | -13.2% |
| Pre-tax Income | -$165.8M | +19.3% |
| Income Tax | $53K | -93.8% |
| Net Income | -$165.9M | +19.6% |
| EPS (Basic) | -$10.80 | +20.9% |
| EPS (Diluted) | -$10.80 | +20.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.8M | -52.7% |
| Short-term Investments | $103.6M | +92.7% |
| Total Assets | $1.51B | +64.9% |
| Total Liabilities | $1.47B | +51.2% |
| Stockholders' Equity | $37.2M | +163.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$166.6M | +56.2% |
| Capital Expenditures | $1.2M | -64.8% |
| Investing Cash Flow | -$661.5M | -360.0% |
| Financing Cash Flow | $714.3M | +198.7% |
| Free Cash Flow | -$167.8M | +56.2% |